UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
American journal of transplantation, ISSN 1600-6135, 01/2018, Volume 18, Issue 1, pp. 197 - 206
liver allograft function/dysfunction | translational research/science | genetics | infectious disease | clinical research/practice | infection and infectious agents | liver disease:immune/inflammatory | liver transplantation/hepatology | Transplantation | Life Sciences & Biomedicine | Surgery | Science & Technology | Prognosis | Prospective Studies | Follow-Up Studies | Liver Transplantation - adverse effects | Bacterial Infections - etiology | Humans | Middle Aged | Male | Mannose-Binding Lectin - genetics | Graft Rejection - mortality | Adult | Female | Graft Rejection - pathology | Postoperative Complications | Genetic Predisposition to Disease | Risk Factors | Genotype | Graft Rejection - etiology | Graft Survival | Liver Transplantation - mortality | Survival Rate | Polymorphism, Genetic | Bacterial Infections - pathology | Aged | Tissue Donors | Bacterial Infections - mortality | Mannose-Binding Lectin - deficiency | Pneumonia | Bacterial infections | Bacterial pneumonia | Genes | Liver | Mortality | Antifungal agents | Mycoses | Septic shock | Risk factors | Genetic polymorphisms | Monosaccharides | Lectins | Health aspects | Sugars | Cytomegalovirus | Transplants & implants | Syngeneic grafts | Infections | Mannose | Graft rejection | Serum levels | Confidence intervals | Allografts | Donors | Mannose-binding lectin | Bacteria | Sepsis | Liver transplantation | Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 01/2013, Volume 309, Issue 3, pp. 275 - 282
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Viral diseases of the respiratory system and ent viral diseases | Infectious diseases | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Community-Acquired Infections - diagnosis | Influenza Vaccines - administration & dosage | Coinfection | Humans | Middle Aged | Critical Illness | Male | Influenza, Human - complications | Staphylococcal Infections - complications | Anti-Bacterial Agents - therapeutic use | Community-Acquired Infections - drug therapy | Pneumonia, Bacterial - mortality | Fatal Outcome | Influenza A Virus, H1N1 Subtype | Influenza, Human - mortality | Influenza, Human - diagnosis | Community-Acquired Infections - complications | Influenza, Human - therapy | Community-Acquired Infections - mortality | Staphylococcal Infections - drug therapy | Pneumonia, Bacterial - complications | Pneumonia, Bacterial - diagnosis | Morbidity | Staphylococcal Infections - mortality | Staphylococcal Infections - diagnosis | Critical Care | Pneumonia, Bacterial - drug therapy | Staphylococcus infections | Systematic review | Immunization | Pandemics | Swine flu | Index Medicus | Abridged Index Medicus
Journal Article
Critical care medicine, ISSN 0090-3493, 10/2019, Volume 47, Issue 10, pp. e851 - e852
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 9/2012, Volume 55, Issue 6, pp. 807 - 815
Hospital costs | Hospitals | Cost estimates | Antimicrobials | Hospital admissions | Urinary tract infections | Infections | Censorship | ARTICLES AND COMMENTARIES | Staphylococcus aureus | Length of stay | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Cross Infection - economics | Community-Acquired Infections - epidemiology | Length of Stay - economics | Urinary Tract Infections - mortality | Humans | Middle Aged | Cross Infection - mortality | Drug Resistance, Bacterial | Bacteremia - mortality | Male | Urinary Tract Infections - economics | Bacteremia - economics | Pneumonia, Bacterial - economics | Case-Control Studies | Bacteremia - microbiology | Hospital Charges - statistics & numerical data | Pneumonia, Bacterial - mortality | Aged, 80 and over | Adult | Female | Urinary Tract Infections - microbiology | Retrospective Studies | Bacterial Infections - microbiology | Length of Stay - statistics & numerical data | Cross Infection - epidemiology | Databases, Factual | Community-Acquired Infections - mortality | Pneumonia, Bacterial - microbiology | Bacterial Infections - economics | Community-Acquired Infections - economics | Pneumonia, Bacterial - epidemiology | Urinary Tract Infections - epidemiology | Health Care Costs | Cross Infection - microbiology | Bacterial Infections - epidemiology | Survival Analysis | Bacteremia - epidemiology | New York City - epidemiology | Aged | Community-Acquired Infections - microbiology | Bacterial Infections - mortality | Infection | Blood-borne diseases | Care and treatment | Economic aspects | Research | Drug resistance | Medical care, Cost of | Hospitalization | Health care expenditures | Bacterial infections | Incentives | Mortality | Index Medicus | and Commentaries
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 01/2018, Volume 18, Issue 1, pp. 95 - 107
C-REACTIVE PROTEIN | COMMUNITY-ACQUIRED PNEUMONIA | GENE-RELATED PEPTIDE | PRIMARY-CARE | EMPIRICAL THERAPY | RANDOMIZED CONTROLLED-TRIAL | DE-ESCALATION | SEPTIC PATIENTS | TRACT INFECTIONS | SEVERE SEPSIS | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Length of Stay | Bacterial Infections - drug therapy | Humans | Middle Aged | Male | Respiratory Tract Infections - drug therapy | Respiratory Tract Infections - diagnosis | Drug-Related Side Effects and Adverse Reactions - epidemiology | Randomized Controlled Trials as Topic | Respiratory Tract Infections - mortality | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Anti-Bacterial Agents - adverse effects | Bacterial Infections - diagnosis | Procalcitonin - blood | Anti-Bacterial Agents - administration & dosage | Bacterial Infections - mortality | Antibiotics | Mortality | Analysis | Lung diseases | Patient outcomes | Pneumonia | Intensive care | Bacterial infections | Procalcitonin | Systematic review | Infections | FDA approval | Patients | Clinical outcomes | Meta-analysis | Studies | Databases | Biomarkers | Sepsis | Bronchitis | Libraries | Viral infections | Ambulatory care | Health care | Bias | Clinical trials | Exposure | Subgroups | Side effects | Reduction | Data collection | Index Medicus
Journal Article
Critical care medicine, ISSN 0090-3493, 03/2019, Volume 47, Issue 3, pp. 345 - 352
Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Pneumonia, Ventilator-Associated - mortality | France - epidemiology | Pneumonia, Bacterial - microbiology | Prospective Studies | Hospital Mortality | Humans | Middle Aged | Risk Factors | Cross Infection - mortality | Proportional Hazards Models | Intensive Care Units - statistics & numerical data | Male | Simplified Acute Physiology Score | Pneumonia, Ventilator-Associated - microbiology | Pneumonia, Bacterial - mortality | Female | Organ Dysfunction Scores | Aged | Index Medicus | Abridged Index Medicus
Journal Article
Clinical microbiology and infection, ISSN 1198-743X, 01/2013, Volume 19, Issue 1, pp. E23 - E30
in-hospital mortality | colistin resistance | Carbapenem resistance | carbapenemase | Klebsiella pneumoniae | in‐hospital mortality | Carbapenemase | In-hospital mortality | Colistin resistance | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Klebsiella pneumoniae - isolation & purification | Klebsiella Infections - drug therapy | Klebsiella pneumoniae - drug effects | Prospective Studies | Hospital Mortality | Humans | Middle Aged | Risk Factors | Male | Klebsiella Infections - microbiology | Molecular Typing | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Colistin - pharmacology | Analysis of Variance | Klebsiella pneumoniae - genetics | Colistin - therapeutic use | Female | Italy - epidemiology | Klebsiella Infections - mortality | Aged | Anti-Bacterial Agents - pharmacology | Drug Resistance, Multiple, Bacterial - genetics | Pneumonia | Bacterial pneumonia | Patient outcomes | Analysis | Mortality | Beta lactamases | Antibacterial agents | Colistin | tigecycline | Multivariate analysis | Epidemiology | Bacteremia | Morbidity | Porins | Risk factors | Infection | Hospitals | Antibiotics | Age | Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 8/2010, Volume 51, Issue 1, pp. S120 - S125
Intensive care units | Health outcomes | Mortality | Hematocrit | Critical care | Clinical trials | Hospital units | Experimentation | Ventilator associated pneumonia | Artificial respiration | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Human infectious diseases. Experimental studies and models | General aspects | Infectious diseases | Respiratory system : syndromes and miscellaneous diseases | Biological and medical sciences | Medical sciences | Pneumology | Pneumonia, Ventilator-Associated - mortality | Humans | Cross Infection - mortality | Treatment Outcome | Clinical Trials as Topic | Cross Infection - drug therapy | Anti-Bacterial Agents - therapeutic use | Hospitals | Time Factors | Pneumonia, Bacterial - mortality | Endpoint Determination | Survival Analysis | Pneumonia, Bacterial - drug therapy | Pneumonia, Ventilator-Associated - drug therapy | Systematic review | Pneumonia | Nosocomial infections | Index Medicus
Journal Article
Gut, ISSN 0017-5749, 02/2017, Volume 66, Issue 2, pp. 330 - 341
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Liver Failure - mortality | Prognosis | Prospective Studies | Urinary Tract Infections - mortality | Humans | Middle Aged | Liver Cirrhosis - mortality | Male | Hepatitis C, Chronic - complications | Liver Neoplasms - mortality | Cause of Death | Incidence | Peritonitis - microbiology | Pneumonia - mortality | Adult | Female | Severity of Illness Index | France - epidemiology | Risk Factors | Survival Rate | Peritonitis - mortality | Hepatitis B, Chronic - complications | Liver Cirrhosis - virology | Liver Cirrhosis - physiopathology | Bacterial Infections - mortality | Coinfection - mortality | Bacterial infections | Diagnosis | Liver cirrhosis | Index Medicus | Abridged Index Medicus | Life Sciences | Microbiology and Parasitology
Journal Article